Men, Why Should You Get Screened for Cancer? Join This Webinar 6/9/22!


Share On Social!

Unfortunately, Latino men have lower cancer screening rates than their White peers.

Only 30% of Latino men received a PSA test for prostate cancer in the past year, compared to 37% of White men. Colorectal cancer screening was lower in Latinos (49%) than Whites (58%), too.

To address this issue, you’re invited to join our webinar — Men, Why Should You Get Screened for Cancer? — at 2 p.m. CT on June 9, 2022.

This Zoom webinar will feature guest speakers and patient advocates to help health care professionals and the Latino public understand the cultural and other barriers to screening, demystify screening tests, and share stories of Latino men’s screening and cancer survival.

This is the fourth webinar of a new series, “Let’s Address Health Equity Together.” The series is a collaboration of the Salud America! program at the Institute for Health Promotion Research at UT Health San Antonio, the Mays Cancer Center at UT Health San Antonio, and Genentech.

Update 6/15/22: 74 registered to attend this webinar. Watch the recording!


Learn about the Webinar Panelists on Implicit Bias

On June 9, 2022, the webinar on Latino men’s cancer screening will feature a moderator and four panelists.

Dr. Amelie Ramirez answering COVID-19 vaccine latino questions
Amelie Ramirez

Dr. Amelie G. Ramirez (moderator), an internationally recognized researcher in Latino health promotion and behavioral change, is director of Salud America! and its home base, the Institute for Health Promotion Research in the Department of Population Health Sciences at UT Health San Antonio. She has spent over 30 years directing research on human and organizational communication to reduce chronic disease and cancer health disparities affecting Latinos, including cancer risk factors, clinical trial recruitment, tobacco prevention, obesity prevention, and promotion of health equity. She also is associate director of cancer outreach and engagement at the NCI-designated Mays Cancer Center at UT Health San Antonio.

Daniel Alvarez MDDr. Daniel Alvarez earned his medical degree from the Institute of Medical Science of Havana, Cuba and the University of Costa Rica. He also holds a master’s degree in Science of Pharmaceutical Medicine from Hibernia College, Ireland and a Diploma in Pharmacoeconomics from La Salle University, Mexico. Dr. Alvarez has over 14 years of experience in Medical Affairs and has supported different therapeutic areas, including oncology, neuroscience, and retina. He joined Roche in 2015 as the Medical Affairs Director for Central America and the Caribbean, leading the entire regional medical operations from regulatory affairs, clinical trials, drug safety to evidence generation. In this role, he experienced and addressed first-hand the challenges of bringing clinical trials and innovative medicine to thousands of patients in Latin America.  He then joined Genentech in 2020 as the Neuroscience Medical Science Liaison Field Director, and in 2021 joined the Heath Equity and Inclusive Research (HEIR) in the United States Medical Affairs team as Principal Medical Director. In his current position, he partners internally and externally to contribute to addressing disparities in health care and the representation of minorities and underserved patients in clinical trials.

Ramon Cancino Dr. Ramon Cancino is an associate professor/clinical in the Department of Family & Community Medicine at UT Health San Antonio, director of the UT Health Physicians Primary Care Center, senior medical director of medical management, and co-chair of UT Health San Antonio Mays Cancer Center Cancer Prevention & Screening Committee. He oversees seven primary care locations delivering patient-centered team-based care to the diverse patient population of San Antonio and South Texas. Practices are staffed by academic primary care clinicians, including family medicine and internal medicine clinicians, pediatricians, gerontologists, pharmacists, and psychologists. He works closely with senior leadership to guide primary care and value-based care strategy and oversees primary care medical directors who lead UT Health San Antonio practices towards organization-wide goals. He oversees cancer prevention and screening activities at UT Health San Antonio and co-leads a committee made up of every medical specialty with a focus on the health equity issues affecting our community. He currently oversees a multi-disciplinary project to enhance lung cancer screening in partnership with American Cancer Society. Prior to working at UT Health San Antonio, he was chief medical officer at a federally qualified health center in Boston, MA. He completed his family medicine resident at Mayo Clinic. He received a master of science in health services research from Boston University School of Public Health and a master in business administration from University of Texas at San Antonio.

Gabe CanalesGabe Canales is a prostate cancer survivor and national activist for men’s health, yet 75 percent of his followers are women. Why? Men tend to resist opening up about their health, but women don’t, and they want to save their male loved ones. Gabe is on a mission to get men more engaged and take life-saving actions. His own such actions began when he was diagnosed at 35 with what’s long been deemed an old man’s disease. Prostate cancer? Gabe was shocked. A carnivore averse to vegetables, he then devoured knowledge from doctors at five top cancer centers, who told him his life had to change. Inspired by his medical team, Gabe became dedicated not just to cure himself but to help others with the “cure” of prevention. He made it his mission to stop life-threatening ailments before they start. Eight years later, Gabe is the hearty, healthy powerhouse behind the nonprofit Blue Cure Foundation, the men’s side of women’s pink breast cancer campaigns. Blue Cure aims to change the cancer conversation. While also helping men with cancer to improve their outcomes and supporting work to find elusive cancer cures, Blue Cure is most focused on cancer prevention.

Daniel G GarzaDaniel G. Garza has been a patient leader for over 20 years. He speaks publicly about HIV diagnosed in September of 2000, Anal Cancer in May 2015, and an Ostomy in April 2016. Daniel shares his story on social media, through several campaigns such as Positively Fearless, volunteers for organizations such as Radiant Health Centers and works with WEGO Health and NMAC as a consultant. Through his company Lilmesican Productions Inc, Daniel and his partner, Christian, produce live stream content that is geared towards adding positive messages to the HIV, Cancer, and LGBTQ communities.


Behind the Webinar Series on Health Equity

This webinar is part of the “Let’s Address Health Equity Together” webinar series.

The series is a collaboration of the Salud America! program at the Institute for Health Promotion Research at UT Health San Antonio, the Mays Cancer Center at UT Health San Antonio, and Genentech.

Salud America! is a national Latino-focused organization that creates culturally relevant and research-based stories, videos, and tools to inspire people to start and support healthy changes to policies, systems, and environments where Latino children and families can equitably live, learn, work, and play.

The Mays Cancer Center, also known as the UT Health San Antonio MD Anderson Cancer Center, has a mission to decrease the burden of cancer in San Antonio, South Texas and beyond. We bring South Texas a level of exceptional care that is comparable with the nation’s most respected programs. More patients put their trust in our program because we have a unique understanding of our community’s cancer care needs. We excel in delivering advanced therapies.

Founded more than 40 years ago as the first biotechnology company, Genentech is dedicated to the rigorous pursuit of science and the development and delivery of life-changing medicines for people facing serious diseases. Headquartered in South San Francisco, California and a proud member of the Roche Group, our community is united by a common purpose and sense of urgency to transform the future of healthcare. Learn more at


Explore More:

Cancer, Healthcare Access

By The Numbers By The Numbers



Expected rise in Latino cancer cases in coming years

Share your thoughts